Prinka Singla

Benzimidazole-biologically attractive scaffold for protein kinase inhibitors

Prinka Singla, Vijay Luxami, Kamaldeep Paul · RSC Advances · 2013 · 113 citations

Drug Target, Attractive Scaffold, Kinase Inhibitors +17

Triazine–benzimidazole hybrids: Anticancer activity, DNA interaction and dihydrofolate reductase inhibitors

Prinka Singla, Vijay Luxami, Kamaldeep Paul · Bioorganic & Medicinal Chemistry · 2015 · 93 citations

Biochemistry, Medicine, Triazine–benzimidazole Hybrids +7

Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin

Prinka Singla, Vijay Luxami, Kamaldeep Paul · European Journal of Medicinal Chemistry · 2016 · 76 citations

Medicinal Chemistry, Pharmaceutical Science, Pharmacology +8

Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies

Prinka Singla, Vijay Luxami, Raja Singh et al. · European Journal of Medicinal Chemistry · 2016 · 62 citations

Medicinal Chemistry, Pharmaceutical Science, Bioorganic Chemistry +12

Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure–activity relationship studies of 1,3,5-triazine analogues

Prinka Singla, Vijay Luxami, Kamaldeep Paul · Bioorganic & Medicinal Chemistry Letters · 2015 · 33 citations · Full text

Medicinal Chemistry, Dihydrofolate Reductase Inhibition, Biochemistry +9